GNRC vs XENE · P/E 82, rev $1.17B vs $2.55B cap
Generac Holdings Inc (GNRC) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
GNRC currently screens at market cap $15.40B and trailing P/E 82.0. XENE currently screens at market cap $2.55B.
Not investment advice. Open the GNRC and XENE stock pages for the full models.
Not investment advice.